M2S to Sponsor Dinner Symposium on Vascular Quality Improvement Registries at Vascular Annual Meeting

M2S Inc., a Clinical Technology Organization and industry leader in endovascular treatment planning and patient data registries, announced today that the company will sponsor a dinner symposium titled "Vascular Quality Improvement Registries" at the 2009 Vascular Annual Meeting on June 12, 2009 in Denver, Colorado. The symposium will demonstrate how participation in a multi-center cooperative patient data registry can improve vascular healthcare, highlighting the six-year experience of the Vascular Study Group of Northern New England (VSGNNE). Participants will learn what to expect from, and how to set up, their own regional registries.

West Lebanon, NH (PRWEB / PRWEB) June 3, 2009 -- M2S Inc., a Clinical Technology Organization and industry leader in endovascular treatment planning and patient data registries, announced today that the company will sponsor a dinner symposium titled "Vascular Quality Improvement Registries" at the 2009 Vascular Annual Meeting on June 12, 2009 in Denver, Colorado.

Clinical Tech Co. M2S will sponsor Dinner Symposium at 2009 Vascular Annual Meeting

The symposium will demonstrate how participation in a multi-center cooperative patient data registry can improve vascular healthcare, highlighting the six-year experience of the Vascular Study Group of Northern New England (VSGNNE). Participants will learn what to expect from, and how to set up, their own regional registries.

Following the symposium will be a demonstration of the M2S web-based system for registry data entry and real-time reporting. This system allows for the sharing of data among centers and regions, and provides benchmark reports and risk-adjusted outcomes.

"M2S is proud to participate in the clinical development of comparative effectiveness registries during this time of significant changes in healthcare delivery and reimbursement in the U.S.," said Wes Chapman, CEO of M2S. "We believe our cost-efficient, high-quality patient data registry solution will elegantly meet the needs of healthcare organizations as they work to enhance clinical quality, increase efficiency, and reduce costs through the provision of clean, combinable data."

The Vascular Quality Improvement Registries symposium will be run by a group of expert panelists from the field, headed by Jack Cronenwett, M.D., of Dartmouth- Hitchcock Medical Center. Other members of the panel include Peter Lawrence, M.D., of UCLA Medical Center, Jens Eldrup-Jorgensen, M.D., of the Maine Surgical Group and John (Jeb) Hallett, M.D., of Roper St. Francis Heart and Vascular Center.

About M2S, Inc.
M2S is a Clinical Technology Organization (CTO) offering services across the healthcare continuum, including clinical trials image management, advanced image analysis and clinical registries designed to provide long-term evaluation of treatment outcomes, benefits and costs. As a CTO, M2S' mission is to increase operational efficiency, reduce total delivered cost, and maintain or enhance clinical quality via the utilization of best-in-class technology and continuous quality improvement processes. M2S is the leading provider of AAA and TAA Treatment Planning using its Preview® Software/Services and its PEMS® (Patient Endovascular Management Services) registry for the vascular surgery field. For more information, visit www.m2s.com.

###

See the original story at: http://www.prweb.com/releases/2009/06/prweb2489504.htm

Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/RW1wdC1aZXRhLVN1bW0tUHJvZi1IYWxmLUNvdXAtWmVybw==